Safety Alert for Accu-Chek Compact test strips and Accu-Chek Mobile tests

According to Department of Health, this safety alert involved a device in Hong Kong that was produced by Roche Diabetes Care.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Date
    2014-04-10
  • Event Country
  • Event Source
    DH
  • Event Source URL
  • Notes / Alerts
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Extra notes in the data
    Press release
  • Reason
    Safety alert over certain brands of roche diabetes care blood glucose test strips and blood glucose monitoring systems the department of health (dh) today (april 10) drew public attention to a safety alert issued by roche diagnostics (hong kong) limited concerning two glucose test strips namely accu-chek compact test strips and accu-chek mobile tests, respectively compatible with its home blood glucose monitoring systems accu-chek compactplus meter and accu-chek mobile meter, manufactured by roche diabetes care. according to the manufacturer, the test strips may lead to erroneously lowered blood glucose readings in patients undergoing ceftriaxone therapy, which is administered intravenously or intramuscularly. this limitation is not described in the product labelling. a spokesman for the dh said that ceftriaxone is a type of antibiotic used for treating a variety of infections such as respiratory infections or lower urinary tract infections. patients with diabetes who are receiving this specific therapy should stop using the affected blood glucose monitoring systems and contact their attending doctors. the spokesman explained that falsely low blood glucose readings may mislead a diabetic patient into inappropriate management of his or her condition, resulting in hyperglycemia. "the dh's enquiry with the local supplier reveals that around 2 000 accu-chek compactplus meters and 200 accu-chek mobile meters have been sold locally," the spokesman said. so far, the dh has not received any local report of adverse events arising from use of the affected products. the company has set up a customer service hotline 2485 7512 or 2485 7508 to answer related enquiries. ends.

Device

  • Model / Serial
  • Product Description
    Press release: Safety alert over certain brands of Roche Diabetes Care blood glucose test strips and blood glucose monitoring system
  • Manufacturer

Manufacturer